Investigational blood biomarker panel may improve detection of pancreatic cancer
Bottom Line: A four-biomarker blood panel of aminopeptidase N (ANPEP), polymeric immunoglobulin receptor (PIGR), CA19-9, and thrombospondin-2 (THBS2) enhanced the detection of pancreatic ductal adenocarcinoma (PDAC) compared to measuring CA19-9 levels alone.
Journal in Which the Study was Published: Clinical Cancer Research, a journal of the American Association for Cancer Research (AACR).
Author: Kenneth S. Zaret, PhD, professor at the Perelman School of Medicine at the University of Pennsylvania.
Background: ...